Zealand Pharma AS (FRA:22Z)
€ 96.55 -0.4 (-0.41%) Market Cap: 6.89 Bil Enterprise Value: 5.80 Bil PE Ratio: 0 PB Ratio: 5.81 GF Score: 67/100

Q1 2019 Zealand Pharma A/S Earnings Call Transcript

May 16, 2019 / 02:00PM GMT
Release Date Price: €18.14 (-0.60%)
Operator

Good afternoon, ladies and gentlemen. Thank you for standing by. Welcome to today's Zealand Pharma Results for the First Quarter of 2019 Conference Call. (Operator Instructions) I must advise you that this conference is being recorded today, Thursday, the 16th of May 2019. And I would now like to hand the conference over to your speaker today, Lani Morvan. Please go ahead.

Lani Pollworth Morvan;S;IR;Communications Officer
Zealand Pharma A

/-&

Thank you, Serena, and welcome to Zealand Pharma's First Quarter Conference Call for Fiscal Year 2019. On today's call, I'm very pleased to welcome Emmanuel Dulac, Zealand's new President and CEO; as well as Adam Steensberg, Zealand's Chief Medical & Development Officer.

Emmanuel will provide business and financial highlights for the first quarter and the period thereafter. Adam will follow with highlights from our research and development programs. After the prepared remarks, we will open the call to take your questions. Joining for the Q&A will be Ivan

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot